Yajima Shugo, Nakanishi Yasukazu, Umino Yosuke, Okubo Naoya, Tanabe Kenji, Kataoka Madoka, Masuda Hitoshi
National Cancer Center Hospital East, 6-5-1 Kashiwa No Ha, Kashiwa City, Chiba, 277-8577 Japan.
Indian J Surg Oncol. 2023 Jun;14(2):361-365. doi: 10.1007/s13193-022-01671-y. Epub 2022 Nov 25.
This case series reported on five patients with radiation-recurrent localized prostate cancer (PCa) who underwent salvage robot-assisted radical prostatectomy (sRARP). Median postoperative follow-up period was 8 months. Median (range) peri-operative parameters such as operative time, the estimated blood loss, and length of hospital stay were 127 min (113-158), 61 ml (54-111), and 9 days (8-11), respectively. None of the five patients required conversion to an open approach or required a blood transfusion, or experienced a rectal/ureteral injury. Urinary leakage was present in one patient (20%) at the initial cystogram. Transurethral electrocoagulation under spinal anesthesia was required to control hematuria in one patient (20%). Two patients (40%) experienced biochemical progression; no patient died from PCa or other causes during the follow-up period. Of five patients, three (60%) were continent. For patients with radiation-recurrent localized PCa, sRARP might become a feasible surgical option with acceptable outcomes.
该病例系列报告了5例接受挽救性机器人辅助根治性前列腺切除术(sRARP)的放射性复发性局限性前列腺癌(PCa)患者。术后中位随访期为8个月。手术时间、估计失血量和住院时间等围手术期参数的中位数(范围)分别为127分钟(113 - 158)、61毫升(54 - 111)和9天(8 - 11)。5例患者均无需转为开放手术、输血或发生直肠/输尿管损伤。1例患者(20%)在初次膀胱造影时有尿漏。1例患者(20%)需要在脊髓麻醉下进行经尿道电凝以控制血尿。2例患者(40%)出现生化进展;随访期间无患者死于PCa或其他原因。5例患者中,3例(60%)控尿良好。对于放射性复发性局限性PCa患者,sRARP可能成为一种可行的手术选择,且结果可接受。